These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33450374)

  • 1. Efficient iron utilization compensates for loss of extracellular matrix of ovarian cancer spheroids.
    Wang Q; Gu T; Ma L; Bu S; Zhou W; Mao G; Wang LL; Guo Y; Lai D
    Free Radic Biol Med; 2021 Feb; 164():369-380. PubMed ID: 33450374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
    Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
    Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM.
    Yang Z; Liu Y; Wei X; Zhou X; Gong C; Zhang T; Jin P; Xu S; Ma D; Gao Q
    Curr Cancer Drug Targets; 2015; 15(3):215-26. PubMed ID: 25619386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
    Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
    J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
    Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
    He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
    Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
    Pan Y; Robertson G; Pedersen L; Lim E; Hernandez-Herrera A; Rowat AC; Patil SL; Chan CK; Wen Y; Zhang X; Basu-Roy U; Mansukhani A; Chu A; Sipahimalani P; Bowlby R; Brooks D; Thiessen N; Coarfa C; Ma Y; Moore RA; Schein JE; Mungall AJ; Liu J; Pecot CV; Sood AK; Jones SJ; Marra MA; Gunaratne PH
    Oncotarget; 2016 May; 7(18):25930-48. PubMed ID: 27036018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
    Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG
    J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
    Ding Y; Labitzky V; Legler K; Qi M; Schumacher U; Schmalfeldt B; Stürken C; Oliveira-Ferrer L
    Mol Oncol; 2021 Dec; 15(12):3578-3595. PubMed ID: 34060699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
    Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
    Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
    Shield K; Riley C; Quinn MA; Rice GE; Ackland ML; Ahmed N
    J Carcinog; 2007 Jun; 6():11. PubMed ID: 17567918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation.
    McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK
    Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.
    Burleson KM; Hansen LK; Skubitz AP
    Clin Exp Metastasis; 2004; 21(8):685-97. PubMed ID: 16035613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions.
    Battaglia AM; Sacco A; Vecchio E; Scicchitano S; Petriaggi L; Giorgio E; Bulotta S; Levi S; Faniello CM; Biamonte F; Costanzo F
    Front Cell Dev Biol; 2023; 11():1272667. PubMed ID: 38033861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.